🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is extension of the V102\_16 study (NCT02140762). V102\_16E1 is design...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-01
Trial ID
NCT02285777
Treatments Being Tested
The aim of this study is to determine the immunologic noninferiority of Men...
Status
Completed
Location
Alabama Clinical Therapeutics, LLC, Birmington Pediatric Assocaites
Start Date
2020-06-17
Trial ID
NCT04440163
Treatments Being Tested
The purpose of this study is to evaluate persistence of bactericidal antibo...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-06-30
Trial ID
NCT02451514
Treatments Being Tested
This study is designed to describe the short-term immunogenicity and safety...
Status
Completed
Location
AMR Clinical
Start Date
2020-06-17
Trial ID
NCT04440176
The aim of the study is to describe the safety, tolerability, and immunogen...
Status
Terminated
Location
Dr. med Falko Panzer Praxis fuer Kinder und Jugendliche
Start Date
2020-11-26
Trial ID
NCT04645966
The purpose of this study is to assess the safety, tolerability, and immuno...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2021-11-18
Trial ID
NCT05087056
Treatments Being Tested
The purpose of the current study is to evaluate whether there is immune int...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-07-09
Trial ID
NCT03587207
Treatments Being Tested
The purpose of this study was to assess immunogenicity and safety of MenABC...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-01-25
Trial ID
NCT04707391
Treatments Being Tested
The main purposes for conducting the study are firstly to assess immunologi...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-08-21
Trial ID
NCT02212457
Treatments Being Tested
The purpose of this phase 2 study is to evaluate the safety, tolerability a...
Status
Completed
Location
CESFAM Gabriela Mistral
Start Date
2010-12
Trial ID
NCT01210885
Treatments Being Tested